NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Albany International Corp. (“Albany” or the “Company”) (NYSE: AIN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Albany and certain of its officers and/or directors have engaged […]
NEW YORK, NY / ACCESS Newswire / September 10, 2025 / – SueWallSt: Class Action Filed Against Novo Nordisk A/S – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between May 7, 2025 and July 28, 2025. If you
NEW YORK, NY / ACCESS Newswire / September 10, 2025 / – SueWallSt: Class Action Filed Against Lockheed Martin Corporation – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between January 23, 2024 and July 21, 2025. If you
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Insperity, Inc. (“Insperity” or the “Company”) (NYSE: NSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Insperity and certain of its officers and/or directors have engaged in
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Fluor Corporation (“Fluor” or the “Company”) (NYSE: FLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fluor and certain of its officers and/or directors have engaged in
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Marex Group PLC (“Marex” or the “Company”) (NASDAQ: MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Marex and certain of its officers and/or directors have engaged
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether agilon and certain of its officers and/or directors have engaged
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Inspire and certain of its officers and/or directors have
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or the “Company”)(NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Confluent and certain of its officers and/or directors have engaged in